ClinicalTrials.gov record
Terminated Phase 1Phase 2 Interventional

ST266 Versus Standard Care In Treating Partial Thickness Burns

ClinicalTrials.gov ID: NCT00886470

Public ClinicalTrials.gov record NCT00886470. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns

Study identification

NCT ID
NCT00886470
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Noveome Biotherapeutics, formerly Stemnion
Industry
Enrollment
16 participants

Conditions and interventions

Conditions

Interventions

  • ST266 Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2009
Primary completion
Feb 28, 2010
Completion
Feb 28, 2010
Last update posted
May 14, 2019

2009 – 2010

United States locations

U.S. sites
14
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
University of South Alabama Dept. of Surgery Mobile Alabama 36617
LAC - USC Medical Center Los Angeles California 90033
Shands Burn Center at the University of Florida Gainesville Florida 32610
University of South Florida / Tampa General Hospital Tampa Florida 33606
Loyola University Medical Center Maywood Illinois 60153
University of Kentucky Chandler Medical Center Lexington Kentucky 40536-0284
Johns Hopkins Burn Center Baltimore Maryland 21224
Brigham and Women's Hospital Boston Massachusetts 02115
University of Missouri Health Care Columbia Missouri 65212
Acute & Critical Care Surgery Barnes Jewish Hospital, Washington University Medical Center St Louis Missouri 63110
University of Rochester Rochester New York 14642
MetroHealth Medical Center Cleveland Ohio 44109
Western Pennsylvania Hospital Pittsburgh Pennsylvania 15224
John S. Dunn Sr. Burn Center Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00886470, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2019 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00886470 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →